Safety of Calcium Antagonists: Dissecting the Evidence
- 7 November 1996
- journal article
- review article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 78 (9), 19-23
- https://doi.org/10.1016/s0002-9149(96)00734-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Heart rate lowering calcium antagonists (HRL-CA) in hypertensive post MI patientsJournal of the American College of Cardiology, 1996
- Calciumantagonisten in der Kontroverse: Gibt es eine rationale Differentialtherapie?*Deutsche Medizinische Wochenschrift (1946), 1996
- Left ventricular systolic and diastolic function, and exercise capacity six to eight weeks after acute myocardial infarctionThe American Journal of Cardiology, 1993
- Update of effects of calcium antagonists in myocardial infarction or angina in light of the second danish verapamil infarction trial (DAVIT-II) and other recent studiesThe American Journal of Cardiology, 1991
- “Cardioprotection” — Not all calcium antagonists are created equalThe American Journal of Cardiology, 1990
- Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)The American Journal of Cardiology, 1990
- Retardation of angiographic progression of coronary artery disease by nifedipineThe Lancet, 1990
- Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.BMJ, 1989
- Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.Cell Metabolism, 1984
- Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison.Cell Metabolism, 1984